A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia
2011 ◽
Vol 31
(2)
◽
pp. 221-225
◽
Keyword(s):
2009 ◽
Vol 2
(2)
◽
pp. 86-92
Keyword(s):
2005 ◽
Vol 81
(1)
◽
pp. 190-197
◽
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 559
(2-3)
◽
pp. 173-179
◽
2011 ◽
Vol 17
(2)
◽
pp. 259-273
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 159
◽
pp. 263-266
◽
Keyword(s):